Skip Navigation LinksHome > September 2002 - Volume 35 - Issue 3 > Protective Effect of Bilirubin in Ischemia-Reperfusion Injur...
Journal of Pediatric Gastroenterology & Nutrition:
Original Articles: Gastroenterology and Hepatology

Protective Effect of Bilirubin in Ischemia-Reperfusion Injury in the Rat Intestine

Hammerman, C.*; Goldschmidt, D.*; Caplan, M. S.†; Kaplan, M.‡§; Bromiker, R.‡; Eidelman, A. I.*; Gartner, L. M.¶; Hochman, A.**

Free Access
Article Outline
Collapse Box

Author Information

*Department of Neonatology, Shaare Zedek Medical Center and the Ben Gurion University of the Negev, Beersheva, Israel; †Department of Perinatal Pediatrics, Evanston Hospital, Evanston, Illinois, U.S.A.; ‡Shaare Zedek Medical Center; §the Hebrew University, Hadassah Medical School, Jerusalem, Israel; ¶Department of Pediatrics, The University of Chicago, Chicago, Illinois, U.S.A.; **Department of Biochemistry, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel

Received July 3, 2001; accepted April 16, 2002.

Supported by grant no. 3302 from the Chief Scientist Office of Ministry of Health of Israel and a generous donation from Mr. and Mrs. Stephen Hammerman.

Address correspondence and reprint requests to Dr. Cathy Hammerman, Department of Neonatology, Shaare Zedek Medical Center, 12 Bayit Street, Jerusalem 91031, Israel (e-mail: cathy@cc.huji.ac.il).

Collapse Box

Abstract

Background: Although bilirubin, which crosses the blood–brain barrier, can cause irreversible brain damage, it also possesses antioxidant properties that may be protective against oxidative stress. Intestinal ischemia–reperfusion (IR) injury results in cell destruction, mediated via the generation of reactive oxygen species. Although increased serum bilirubin is correlated with increased antioxidant potential in the face of hyperoxia, evidence of bilirubin-associated protective effect against IR injury remains nonspecific. We therefore sought to investigate whether hyperbilirubinemia would be protective against IR injury to the intestine.

Methods: Young adult rats were randomly assigned to one of three groups: 1) IR/control (n = 12); 2) IR/hyperbilirubinemia (n = 10), in which IR was generated while the rats were treated with a continuous infusion of bilirubin; and 3) hyperbilirubinemia controls (n = 10). Blood and intestinal tissue samples were obtained to determine serial thiobarbituric acid reducing substances (index of lipid peroxidation) and for xanthine oxidase/xanthine dehydrogenase and glutathione/glutathione disulfide ratios. Intestinal histopathology was graded from 1 (normal) to 4 (severe necrotic lesions).

Results: Histopathologic scoring and circulating and tissue thiobarbituric acid reducing substances were highest in the IR/control animals compared with either the IR/hyperbilirubinemics or the controls. All of these are consistent with the most severe injury in this group. Xanthine oxidase/xanthine dehydrogenase ratios were not significantly different among the groups.

Conclusion: Hyperbilirubinemia ameliorates the extent of intestinal IR injury in our model and appears to act as an antioxidant. This study supports the concept that bilirubin possesses some beneficial properties in vivo, although no direct clinical conclusions can be drawn from these data.

Neonatal hyperbilirubinemia remains a teleologic enigma. Although it is clear that bilirubin can cross the blood–brain barrier and can cause irreversible brain damage and even death, it is also true that bilirubin possesses antioxidant properties that can be protective in the face of oxidative stress.

Although increased serum bilirubin concentrations have been correlated with total antioxidant potential and bilirubin antioxidant properties have been demonstrated to be protective in a rat model exposed to hyperoxia (1), evidence of bilirubin-associated in vivo protective effect against oxidative stress remains nonspecific. Human clinical studies must, by definition, be clinical surveys showing at best an association between hyperbilirubinemia and clinical outcome of reactive oxygen species–mediated pathology. The results of such studies have been understandably contradictory. First, clinical disease is multifactorial, and the role of bilirubin may be concealed behind multiple other risk factors. With this in mind, we sought to investigate whether jaundice is protective, in an in vivo animal model, against ischemic reperfusion injury to the intestine. Second, although it might be expected that hyperbilirubinemia would be associated with improved antioxidant potential and thus improved outcome, bilirubin may also be consumed during the process, and thus patients with better outcomes may be associated with lower rather than higher bilirubin concentrations.

This model was chosen because the intestine is extremely sensitive to oxidative stress and thus would appear to be a good test of bilirubin's antioxidant properties. Ischemia predisposes the gut to subsequent injury. With reperfusion and the reintroduction of oxygen, reactive oxygen species are generated. It is these potentially toxic reactive oxygen species that, in turn, promote cell destruction and bowel necrosis via peroxidation of membrane lipids (2–4) and that potentially could be inhibited by bilirubin.

Back to Top | Article Outline

METHODS

Young adult rats were anesthetized with 60 mg/kg intraperitoneal pentobarbital. The intestinal vasculature was exposed via a midline surgical incision, and the superior mesenteric artery was isolated. The abdominal wall was then reapproximated and secured with clamps to prevent evaporative losses, while maintaining easy access for observation and further intervention. Thirty minutes after surgical preparation, baseline blood samples were obtained. Blood samples were obtained from the inferior vena cava by micropuncture using 25-gauge needles. The rats were then randomly assigned to one of the following three groups: 1) group 1, ischemia–reperfusion (IR)/control: after preparation as described above, flow in the superior mesenteric artery (which had been surgically isolated earlier) was occluded with a mosquito clamp; after 45 minutes of occlusion, perfusion was reestablished by opening the clamp; 2) group 2, IR/hyperbilirubinemia: same as IR protocol described above, with a continuous infusion of bilirubin; 3) group 3, hyperbilirubinemia/control (no IR): sham surgical preparation as described, but these animals were not subjected to IR; bilirubin was infused as described above.

Blood samples (1 mL) were taken from all animals in all groups at baseline (30 minutes after completion of surgery), at the end of 45 minutes of ischemia for IR groups (75 minutes after surgery), and after 15 and 30 minutes of reperfusion for the IR groups (90 and 120 minutes after surgery). Samples were immediately frozen in liquid nitrogen and stored at −80°C. These samples were subsequently assayed for thiobarbituric acid reducing substances (TBARS), a measure of lipid peroxidation and for serum bilirubin concentrations. At the conclusion of the experiment, intestinal tissue samples were taken from the distal ileum, immediately frozen in liquid nitrogen, and stored at −80°C for measurement of tissue xanthine oxidase (XO)/xanthine dehydrogenase (XD) and reduced glutathione. Other intestinal samples were obtained and fixated in formalin for histologic examination with hematoxylin and eosin staining. This study was approved by the institutional review board of the Shaare Zedek Medical Center for the care of animals using local guidelines.

Back to Top | Article Outline
Bilirubin Administration

Bilirubin was dissolved in 0.1 N NaOH, stabilized with 5% bovine serum albumin, and then diluted with 0.055 mol/L sodium phosphate buffer to a final pH of approximately 8.0 (final concentration of approximately 7 mg/4.5 mL). Each rat selected for hyperbilirubinemia was given a loading dose of 15 mg/kg bilirubin intravenously over 10 minutes, followed by 30 mg/kg intravenously over the ensuing 75 minutes.

Back to Top | Article Outline
Laboratory Determinations
Histopathology

Lesions were graded by a blinded observer based on hematoxylin and eosin–stained histologic slides and were assigned a necrotizing enterocolitis (NEC) score on a scale of 0 to 4 as follows: 0 = normal, intact villous epithelium with normal histology; 1 = mild villous edema, with epithelial sloughing confined to the tips of the villi; 2 = mild midvillous necrosis; 3 = moderate midvillous necrosis, with crypts still readily detectable; and 4 = severe necrosis of entire villi with complete absence of epithelial structures.

Back to Top | Article Outline
Thiobarbituric Acid Reacting Substances (TBARS)

Blood (300 μL) was collected in EDTA anticoagulant, snap frozen in liquid nitrogen, and then maintained frozen at −80°C pending analysis of TBARS (5).

Back to Top | Article Outline
Xanthine Oxidase (XO)/Xanthine Dehydrogenase (XD)

Intestinal tissue (500 mg) was homogenized on ice in 0.03 mol/L potassium phosphate buffer (pH 7.4) containing 1 mmol/L dithiothrietol to prevent oxidative conversion of XD to XO in solution, 1 mmol/L EDTA, and the protease inhibitors, 1 mmol/L phenylmethylsulfonyl fluoride and 1 mg/ml leupeptin. The homogenate was then centrifuged at 110,000 x g for 20 minutes at 4°C. The supernatant collected and centrifuged a second time for 10 minutes, and activity was assayed as soon as possible to avoid further changes in the enzymes. XO and XD activities were measured spectrophotometrically and recorded as described (6), and the ratio of XO to XD activity was calculated.

Back to Top | Article Outline
Glutathione/glutathione disulfide ratios (GSSG/GSH)

Glutathione/glutathione disulfide ratios were assayed with a Calbiochem kit (Calbiochem; Novabiochem, La Jolla, CA, U.S.A.). Protein was determined by the Bradford method (7), a rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein dye binding with bovine serum albumin as standard.

Back to Top | Article Outline
Analysis of Data

Results are expressed as mean ± SD. Two-way analysis of variance with repeated measures was used to determine the effects of time, group, and group–time interaction for serial TBARS. One-way analysis of variance was used to compare values of single variables among groups. Significant differences were accepted at P < 0.05. Post hoc comparisons were conducted with Tukey pairwise comparisons. Paired t tests were used to compare values with baseline values within each group. Statistical analysis was conducted with Sigmastat for Windows.

Back to Top | Article Outline

RESULTS

Thirty-two rats were studied: 12 subjected to IR (IR controls), 10 subjected to IR with hyperbilirubinemia (IR/hyperbilirubinemia), and 10 not subjected to IR but with hyperbilirubinemia (hyperbilirubinemia controls; subjected to a sham surgical procedure similar to that of the IR group). Mean weights were 246 g ± 53 g, 213 g ± 37 g, and 205 g ± 18 g for the IR control, IR/hyperbilirubinemia, and hyperbilirubinemia control groups, respectively. Although there was a trend toward lower birth weight in the hyperbilirubinemia control group, these differences were not significant (P = 0.05). By design, mean serum bilirubin concentrations at the conclusion of the procedure were significantly different in the IR control group than in the two hyperbilirubinemic groups, which were similar to each other (< 1 mg/dL ± 0.4 mg/dL, 17 mg/dL ± 4 mg/dL, 15 mg/dL ± 5 mg/dL, respectively;P < 0.001; 1 vs. 2; 1 vs. 3). In both hyperbilirubinemic groups, serum bilirubin steady states (≥ 13 mg/dL) were achieved from 15 minutes after baseline and continued throughout the experiment.

Back to Top | Article Outline
Histopathology: NEC Scores

All of the IR control animals had evidence of severe injury, with a mean score of 4.0 ± 0.0. Animals subjected to IR while hyperbilirubinemic had less severe injury, with a mean score of 2.8 ± 0.4 (Table 1). Hyperbilirubinemic animals without IR had predominantly normal intestinal architecture, with a histopathologic score of 0.7 ± 0.8. These differences were significant at P < 0.0001, with subsequent Tukey pairwise comparisons showing significant differences among the groups. Representative histopathologic specimens taken from the animals are presented in Figure 1.

Table 1
Table 1
Image Tools
Fig. 1
Fig. 1
Image Tools
Back to Top | Article Outline
Thiobarbituric Acid Reducing Substances
Circulating thiobarbituric acid reducing substances

Figure 2 depicts serial values for TBARS (presented as % baseline) for each of the groups at baseline and after 45 minutes of ischemia and 15, 30, and 45 minutes of reperfusion. We found significantly increased TBARS, indicative of increased lipid membrane peroxidative damage, only in the IR control animals. This finding is consistent with the previously described histopathologic observations.

Fig. 2
Fig. 2
Image Tools
Back to Top | Article Outline
Tissue thiobarbituric acid reducing substances

Tissue TBARS, like circulating TBARS, were significantly and extremely elevated in the IR control group compared with either of the hyperbilirubinemic groups (Table 1). TBARS in the hyperbilirubinemic rats were similar with and without IR.

Back to Top | Article Outline
Oxidant/antioxidant balance

XO/XD ratios were not significantly different across the groups, although there was a trend toward higher ratios in the IR group compared with the control group (Table 1). Glutathione/glutathione disulfide ratios were reduced in the IR control animals compared with both other groups.

Back to Top | Article Outline

DISCUSSION

Reactive oxygen species are generated continuously during physiological conditions. These potentially toxic reactive oxygen species are highly reactive substances that promote cell damage via lipid membrane peroxidation. Once lipid peroxidation is initiated, it self-propagates until terminated by some antioxidant. The mammalian body has an extensive network of protective antioxidant defenses; however, overproduction of free radicals or inadequate antioxidant defenses can disrupt the natural balance, leading to oxidative damage.

Bilirubin is one of the body's natural antioxidants, contributing up to 10% to 30% of the total antioxidant status of premature infants (8,9). Furthermore, during the first postnatal days when general antioxidant defenses are reduced, serum bilirubin is physiologically increased, conceivably implying some beneficial role for this physiological hyperbilirubinemia (9).

It has been proposed that hyperbilirubinemia might protect against oxidative injury. To date, human studies of bilirubinemia and oxygen radical–associated diseases have been retrospective and observational. Because clinical diseases are multifactorial and potential risk factors cannot be controlled for in retrospective studies, results remain contradictory and inconclusive. Some investigators (10,11) have noted lower bilirubin concentrations in neonates with oxygen radical–mediated diseases as compared with controls, implying that bilirubin may be consumed in response to oxygen free radicals. Conversely, a retrospective study of early bilirubin concentrations in relation to the subsequent development of retinopathy of prematurity (12) did not show any such correlation. By definition, such studies are hampered by the fact that any relation between clinical disease and bilirubin is likely to be more complex than a direct correlation. Oxidative stress may consume available antioxidant resources, or, conversely, it may induce antioxidant release (13) or some combination thereof.

Animal studies offer the opportunity to focus investigations on specific factors and to limit confounding variables. In an interesting study by Clark et al. (14), increased endogenous bilirubin production was shown to provide cardioprotection against postischemic–reperfusion injury. Although consistent with our findings, there are several important differences between our study and that of Clark et al. (14). First, heme oxygenase induction also leads to release of carbon monoxide, a vasoactive compound that may contribute to observed vascular effects. Second, this study dealt with an isolated heart preparation, not with an intact animal model and not with intestinal lesions. In another study, Dennery et al. (1) demonstrated that Gunn rats exposed to hyperoxia had less oxidative damage, as evidenced by reduced concentrations of lipid peroxides, conjugated dienes, and carbonyl proteins, than did nonjaundiced rats. However, in homozygous Gunn rats, serum bilirubin concentrations reach approximately 8 mg/dL, considered physiologic in term human neonates. We therefore felt it was important to extend these studies of the protective bilirubin effects in an intact animal model to higher bilirubin concentrations.

The intestinal mucosa is known to be exquisitely sensitive to IR injury. Its baseline high rate of oxygen use renders the intestine relatively incapable of increasing oxygen transport in the face of hypoxic stress and thus more susceptible to ischemic injury. Intestinal ischemia predisposes the gut to subsequent necrosis. Evidence suggests, however, that while sustained blood flow reduction damages the intestine mucosa, restoration of flow and reintroduction of oxygen after deprivation accelerates tissue injury (2).

As predicted, there was significantly less histopathologic and biochemical evidence of damage in hyperbilirubinemic animals than in controls when exposed to similar degrees of IR. Microscopically, there were diffuse necrotic lesions with severe villous necrosis throughout the intestines of the IR control animals, as compared with significantly milder damage in the IR hyperbilirubinemia group. TBARS were significantly also significantly elevated in IR control animals, further suggesting that hyperbilirubinemia protected against lipid membrane peroxidation (15,16).

Xanthine oxidoreductase is an enzyme that plays a major role in the generation of toxic superoxide radicals. It has two forms—the dehydrogenase and the oxidase—which coexist in vivo. During normal physiologic conditions, the dehydrogenase predominates. During ischemia, XDe is converted into XO, which then becomes a major source for toxic superoxide radical production once the tissues are reperfused and oxygen is reintroduced (17). In most species, the intestine is one of the richest sources in the body of XO, an enzyme that exhibits a gradient of increasing activity from the intestinal villous bases to the tips. This gradient might explain the fact that the villous tips of the intestine are more susceptible to postischemic damage than are the bases (18), as seen in both our model and in clinical necrotizing enterocolitis. Because ischemia increases the relative predominance of the oxidase form of the enzyme, an elevated XO/XD ratio indicates ischemic insult. In our animals, there was a trend toward an increase in this ratio in the IR controls; however the differences were not significant.

Because it is recyclable and abundant in many cell types, glutathione is an important nonenzymatic antioxidant. Peroxidation of endogenous lipids leads to the conversion of reduced glutathione to glutathione disulfide (19,20). Glutathione-depleted tissues are more susceptible to subsequent oxidative stress. This is evident in our IR control animals as compared with the other two groups.

In summary, we have confirmed that intestinal IR generates severe histopathologic and biochemical injury associated with increased lipid peroxidation. We have further shown in vivo, in our animal model, that hyperbilirubinemia acts as an antioxidant in ameliorating the extent of this injury, both histopathologically and biochemically. This study adds support to the concept that bilirubin may possess some beneficial as well as toxic properties. Any potential clinical relevance of these data to the premature neonate must, however, take into consideration the fact that serum bilirubin concentrations such as those generated in the current study can be neurotoxic in the human premature. Clearly, no clinical conclusions can be drawn from these data, pending further study.

Back to Top | Article Outline

REFERENCES

1. Dennery PA, McDonagh AF, Spitz DR, et al. Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med 1995; 19:395–404.

2. Schoenberg MH, Berger HG. Reperfusion injury after intestinal ischemia. Crit Care Med 1993; 21:1376–86.

3. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: Implications for neonatal disease. Acta Paediatr 1996; 85:1–4.

4. Parks DA, Bulkley GB, Granger DN, et al. Ischemic injury in the cat small intestine: Role of superoxide radicals. Gastroenterology 1982; 82:9–15.

5. Ernster L, Nordenbrand K. Microsomal lipid peroxidation. Methods Enzymol 1967; 10:574–80.

6. Kooij A, Schiller HJ, Schijns M, et al. Conversion of Xanthine dehydrogenase into xanthine oxidase in rat liver and plasma at the onset of reperfusion after ischemia. Hepatology 1994; 19:1488–95.

7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248–54.

8. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 1988; 85:9748–52.

9. Hammerman C, Goldstein R, Kaplan M, et al. Bilirubin in the premature: Toxic waste or natural defense? Clin Chem 1998; 44:2551–3.

10. Benaron DA, Bowen FW. Variation of initial serum bilirubin rise in newborn infants with type of illness. Lancet 1991; 338:78–81.

11. Hegyi T, Goldie E, Hiatt M. The protective role of bilirubin in oxygen radical diseases of the preterm infant. J Perinatol 1994; 14:296–300.

12. Gaton DD, Gold J, Axer Siegel R, et al. Evaluation of bilirubin as a possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol 1991; 75:532–4.

13. Romeo MG, Tina LG, Scuderi A, et al. Variations of blood bilirubin levels in the newborn with and without retinopathy of prematurity (ROP). Pediatr Med Chir 1994; 16:59–62.

14. Clark JE, Foresti R, Sarathchandra P, et al. Heme oxygenase-1 derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000; 278:H643–51.

15. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186:407–21.

16. Wojciech W, Neve J, Peretz A. Optimized steps in fluorimetric determination of thiobarbituric acid reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39:2522–6.

17. Parks DA, Granger DN. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand 1986; 548(suppl):87–99.

18. Granger DN, Hollwarth MA, Parks DA. Ischemic reperfusion injury: Role of oxygen derived free radicals. Acta Physiol Scand 1986; 548:47–63.

19. Hansen TN, Smith CV, Gest AL, et al. Biochemical manifestations of oxygen toxicity in the newborn lamb. Pediatr Res 1990; 28:613–7.

20. Adams Jr, JD Lauterburg BJ, Mitchell JR. Plasma glutathione and glutathione disulfide in the rat: Regulation and response to oxidative stress. J Pharmacol Exp Ther 1983; 227:749–54.

Cited By:

This article has been cited 28 time(s).

Digestive Diseases and Sciences
Ischemia-reperfusion injury of the intestine and protective strategies against injury
Mallick, IH; Yang, WX; Winslet, MC; Seifalian, AM
Digestive Diseases and Sciences, 49(9): 1359-1377.

Journal of Clinical Biochemistry and Nutrition
Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemin/reperfusion injury
Nakao, A; Kaczorowskil, DJ; Sugimoto, R; Billiar, TR; McCurry, KR
Journal of Clinical Biochemistry and Nutrition, 42(2): 78-88.

Faseb Journal
Endothelial STAT3 is essential for the protective effects of HO-1 in oxidant-induced lung injury
Zhang, XC; Shan, PY; Jiang, G; Zhang, SSM; Otterbein, LE; Fu, XY; Lee, PJ
Faseb Journal, 20(): 2156-+.
10.1096/fj.06-5668fje
CrossRef
Journal of Gastroenterology and Hepatology
Prophylaxis with mesna prevents oxidative stress induced by ischemia reperfusion in the intestine via inhibition of nuclear factor-kappa B activation
Ypsilantis, P; Tentes, I; Lambropoulou, M; Anagnostopoulos, K; Papadopoulos, N; Kortsaris, A; Simopoulos, C
Journal of Gastroenterology and Hepatology, 23(2): 328-335.
10.1111/j.1440-1746.2007.05154.x
CrossRef
World Journal of Surgery
Proanthocyanidin Protects Intestine and Remote Organs Against Mesenteric Ischemia/Reperfusion Injury
Sizlan, A; Guven, A; Uysal, B; Yanarates, O; Atim, A; Oztas, E; Cosar, A; Korkmaz, A
World Journal of Surgery, 33(7): 1384-1391.
10.1007/s00268-009-0011-9
CrossRef
World Journal of Gastroenterology
Role of neuronal nitric oxide synthase and inducible nitric oxide synthase in intestinal injury in neonatal rats
Lu, H; Zhu, B; Xue, XD
World Journal of Gastroenterology, 12(): 4364-4368.

Current Pharmaceutical Design
Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
Tell, G; Gustincich, S
Current Pharmaceutical Design, 15(): 2908-2914.

Hearing Research
Induction of heat shock protein 32 (Hsp32) in the rat cochlea following hyperthermia
Fairfield, DA; Kanicki, AC; Lomax, MI; Altschuler, RA
Hearing Research, 188(): 1-11.
10.1016/S0378-5955(03)00369-1
CrossRef
Pediatrics
Bilirubin benefits: Cellular protection by a biliverdin reductase antioxidant cycle
Sedlak, TW; Snyder, SH
Pediatrics, 113(6): 1776-1782.

Jama-Journal of the American Medical Association
Messenger molecules and cell death - Therapeutic implications
Sedlak, TW; Snyder, SH
Jama-Journal of the American Medical Association, 295(1): 81-89.

European Journal of Pharmacology
Cytoprotection of human endothelial cells from menadione cytotoxicity by caffeic acid phenethyl ester: The role of heme oxygenase-1
Wang, XY; Stavchansky, S; Zhao, BT; Bynum, JA; Kerwin, SM; Bowman, PD
European Journal of Pharmacology, 591(): 28-35.
10.1016/j.ejphar.2008.06.017
CrossRef
Gastroenterology
Biliverdin protects the functional integrity of a transplanted syngeneic small bowel
Nakao, A; Otterbein, LE; Overhaus, M; Sarady, JK; Tsung, A; Kimizuka, K; Nalesnik, MA; Kaizu, T; Uchiyama, T; Liu, F; Murase, N; Bauer, AJ; Bach, FH
Gastroenterology, 127(2): 595-606.
10.1053/j.gastro.2004.05.059
CrossRef
Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie
Hypocapnia attenuates mesenteric ischemia-reperfusion injury in a rat model
Duggan, M; Engelberts, D; Jankov, RP; Worrall, JMA; Qu, R; Hare, GMT; Tanswell, AK; Mullen, JB; Kavanagh, BP
Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie, 52(3): 262-268.

Renal Failure
Ameliorative Effects of Proanthocyanidin on Renal Ischemia/Reperfusion Injury
Yanarates, O; Guven, A; Sizlan, A; Uysal, B; Akgul, O; Atim, A; Ozcan, A; Korkmaz, A; Kurt, E
Renal Failure, 30(9): 931-938.
10.1080/08860220802359410
CrossRef
Emergency Medicine Clinics of North America
Mesenteric ischemia
Martinez, JP; Hogan, GJ
Emergency Medicine Clinics of North America, 22(4): 909-+.
10.1016/j.emc.2004.05.002
CrossRef
American Journal of Physiology-Gastrointestinal and Liver Physiology
Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators
Overhaus, M; Moore, BA; Barbato, JE; Behrendt, FF; Doering, JG; Bauer, AJ
American Journal of Physiology-Gastrointestinal and Liver Physiology, 290(4): G695-G703.
10.1152/ajpgi.00152.2005
CrossRef
Journal of Surgical Research
Mesna protects intestinal mucosa from ischemia/reperfusion injury
Ypsilantis, P; Lambropoulou, M; Tentes, I; Kortsaris, A; Papadopoulos, N; Simopoulos, C
Journal of Surgical Research, 134(2): 278-284.
10.1016/j.jss.2005.12.031
CrossRef
Antioxidants & Redox Signaling
Therapeutic applications of bilirubin and biliverdin in transplantation
Ollinger, R; Wang, H; Yamashita, K; Wegiel, B; Thomas, M; Margreiter, R; Bach, FH
Antioxidants & Redox Signaling, 9(): 2175-2185.
10.1089/ars.2007.1807
CrossRef
Clinical Biochemistry
Oxidative stress in patients with non-complicated malaria
Pabon, A; Carmona, J; Burgos, LC; Blair, S
Clinical Biochemistry, 36(1): 71-78.
10.1016/S0009-9120(02)00423-X
CrossRef
American Journal of Physiology-Renal Physiology
Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy
Neto, JS; Nakao, A; Toyokawa, H; Nalesnik, MA; Romanosky, AJ; Kimizuka, K; Kaizu, T; Hashimoto, N; Azhipa, O; Stolz, DB; Choi, AMK; Murase, N
American Journal of Physiology-Renal Physiology, 290(2): F324-F334.
10.1152/ajprenal.00026.2005
CrossRef
Gut
Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes
Granato, A; Gores, G; Vilei, MT; Tolando, R; Ferraresso, C; Muraca, M
Gut, 52(): 1774-1778.

Surgery Today
alpha-Lipoic Acid and Ebselen Prevent Ischemia/Reperfusion Injury in the Rat Intestine
Guven, A; Tunc, T; Topal, T; Kul, M; Korkmaz, A; Gundogdu, G; Onguru, O; Ozturk, H
Surgery Today, 38(): 1029-1035.
10.1007/s00595-007-3752-9
CrossRef
Digestive Diseases and Sciences
Increased antioxidant capacity of serum did not prevent lipid peroxidation in the intermittent ischemia-reperfusion of rat small intestine
Cizova, H; Papezikova, I; Kubala, L; Lojek, A; Ciz, M
Digestive Diseases and Sciences, 51(4): 657-661.
10.1007/s10620-006-3188-x
CrossRef
Advances in Clinical Chemistry, Vol 43
The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases
Vitek, L; Schwertner, HA
Advances in Clinical Chemistry, Vol 43, 43(): 1-57.
10.1016/S0065-2423(06)43001-8
CrossRef
Medical Hypotheses
"latrogenic Gilbert syndrome" - A strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin
McCarty, MF
Medical Hypotheses, 69(5): 974-994.
10.1016/j.mehy.2006.12.069
CrossRef
Journal of Clinical Biochemistry and Nutrition
Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents
Sasaki, M; Joh, T
Journal of Clinical Biochemistry and Nutrition, 40(1): 1-12.

World Journal of Gastroenterology
Heme oxygenase-1 and gut ischemia/reperfusion injury: A short review
Liao, YF; Zhu, W; Li, DP; Zhu, X
World Journal of Gastroenterology, 19(): 3555-3561.
10.3748/wjg.v19.i23.3555
CrossRef
Cardiology in Review
Pharmacologic Management of Mesenteric Occlusive Disease
Frishman, WH; Novak, S; Brandt, LJ; Spiegel, A; Gutwein, A; Kohi, M; Rozenblit, G
Cardiology in Review, 16(2): 59-68.
10.1097/CRD.0b013e31815a6600
PDF (365) | CrossRef
Back to Top | Article Outline
Keywords:

Ischemia/reperfusion; Pentoxifylline; Xanthine oxidase; Xanthine dehydrogenase; Reduced glutathione; Thiobarbituric acid reducing substances; Reactive oxygen species

© 2002 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Images

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

 

 

Twitter

twitter.com/JPGNonline

 

Visit JPGN.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.